FDA Clears Cleaning Claim on Medivators Advantage Plus Endoscope Reprocessing System

Minntech Corporation announces that the Food and Drug Administration (FDA) has cleared the Medivators Advantage(R) Plus Endoscope Reprocessing System with a new cleaning cycle claim that provides facilities the option to eliminate the manual cleaning of endoscopes prior to placement in the Advantage Plus when selecting a cycle that includes a wash phase.

The Medivators ADVANTAGE Plus Endoscope Reprocessing System, using Rapicide(R) PA High Level Disinfectant and Intercept(R) Detergent, provides cleaning and high level disinfection of heat sensitive semi-critical endoscopes between patient procedures. 

The Advantage Plus cleaning cycle utilizes Intercept Detergent, a non-enzymatic detergent that provides superior removal of biological and organic soils and effectively penetrates bacterial biofilms found on and in endoscopes. High-level disinfection is achieved with single-use, environmentally friendly Rapicide PA High-Level Disinfectant used at a low 30 degree Celsius temperature.

Additional features of the Medivators ADVANTAGE Plus include: individual endoscope channel monitoring for blockage and proper flow ensuring complete high-level disinfection, a computerized detection system that eliminates human error in the connection of hook-ups, an on-board data management system for tracking scope usage and viewing cycle logs with full networking capabilities, and remote diagnostics for fast technical support.

Advantage Plus units already installed into hospitals, clinics and surgery centers may be upgraded to perform the FDA-cleared cleaning cycle.